The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Antidepressants, such as Prozac, are already used to treat the condition but Canadian and Italian scientists set out to ...

Chinese actress Zhao Lusi has made her first public appearance following a month-long treatment for depression, capturing ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD ...

Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...

There are many different treatment options available ... but you'll need a prescription for some brands. Their effects are similar, but prescription sprays may be stronger or target different ...